Antigen-triggered activation of T cells leads to a sequence of differe
ntiation steps including up-regulation of activation markers, blast fo
rmation, proliferation, delivery of effector functions, and ultimately
apoptosis. It is still controversial in which anatomical site activat
ion-induced apoptosis and elimination of T cells occur. To address thi
s question, we used mice transgenic for a T cell receptor (F5) specifi
c for an influenza virus nucleoprotein peptide (NP68) presented on the
major histocompatibility complex H-2 D-b molecule. Accumulation and a
poptosis of T cells was studied using terminal deoxynucleotidyl transf
erase-mediated dUTP-biotin nick end-labeling in situ combined with imm
unohistology after intraperitoneal injection of the cognate peptide in
to F5 mice which are wild type or deficient for Rag 1. After 4 days of
peptide treatment, large perivascular infiltrations of CD8(+) cells w
ere observed in liver, lung, and kidney of F5 mice. CD8(+) cell number
s were also increased in skin and small intestine, but not in brain or
heart muscle of peptide-treated animals. The infiltrating CD8(+) cell
s show an increased percentage of apoptosis in liver, lung and, most s
trikingly, the kidney. These data suggest that in the F5 system, T cel
l disposal after activation occurs in a number of organs. Essentially
identical findings were obtained in Rag-1(+/+) and Rag-1(-/-) F5 mice,
suggesting that the deletion mechanism did not involve other T or B c
ells.